NASDAQ:PCVX
Vaxcyte, Inc.
- Stock
industry
Biotechnologyexchange
NASDAQ Global Selectwebsite
vaxcyte.comipo date
Jun 12, 2020full time employees
158currency
USD
Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pn...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus